e-Therapeutics Plc (ETX):企業の財務・戦略的SWOT分析

◆英語タイトル:e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1685
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥14,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

e-Therapeutics Plc (ETX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

e-Therapeutics Plc (e-Therapeutics) is a drug discovery and development company with focus on discovering novel therapeutic approaches and mechanisms for the treatment of various disease such as cancer, diabetes and neurodegenerative disease. The company harnesses its two proprietary, productive and unique technology platform namely; Network-Driven Drug Discovery (NDD) and Genome Associated Network Interactions (GAINs) for target validation and novel discovery. e-Therapeutics has research partnership with Novo Nordisk for developing therapeutics for type 2 diabetes. e-Therapeutics is headquartered in Long Hanborough, England, the UK.

e-Therapeutics Plc Key Recent Developments

Mar 23,2020 e-therapeutics: Anti-viral drug discovery initiative
Oct 07,2019 e-therapeutics: Interim Financial Results for the six months ended 31 July 2019
Aug 13,2019 e-Therapeutics to work with top 5 Global pharma company on Neurodegeneration Drug discovery Project
Mar 05,2019 e-therapeutics: Results for the year ended 31 January 2019

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
e-Therapeutics Plc – Key Facts
e-Therapeutics Plc – Key Employees
e-Therapeutics Plc – Key Employee Biographies
e-Therapeutics Plc – Major Products and Services
e-Therapeutics Plc – History
e-Therapeutics Plc – Company Statement
e-Therapeutics Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
e-Therapeutics Plc – Business Description
e-Therapeutics Plc – SWOT Analysis
SWOT Analysis – Overview
e-Therapeutics Plc – Strengths
e-Therapeutics Plc – Weaknesses
e-Therapeutics Plc – Opportunities
e-Therapeutics Plc – Threats
e-Therapeutics Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
e-Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
e-Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
e-Therapeutics Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 23, 2020: e-therapeutics: Anti-viral drug discovery initiative
Oct 07, 2019: e-therapeutics: Interim Financial Results for the six months ended 31 July 2019
Aug 13, 2019: e-Therapeutics to work with top 5 Global pharma company on Neurodegeneration Drug discovery Project
Mar 05, 2019: e-therapeutics: Results for the year ended 31 January 2019
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
e-Therapeutics Plc, Key Facts
e-Therapeutics Plc, Key Employees
e-Therapeutics Plc, Key Employee Biographies
e-Therapeutics Plc, Major Products and Services
e-Therapeutics Plc, History
e-Therapeutics Plc, Other Locations
e-Therapeutics Plc, Subsidiaries
e-Therapeutics Plc, Key Competitors
e-Therapeutics Plc, Ratios based on current share price
e-Therapeutics Plc, Annual Ratios
e-Therapeutics Plc, Annual Ratios (Cont...1)
e-Therapeutics Plc, Interim Ratios
e-Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
e-Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
e-Therapeutics Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
e-Therapeutics Plc, Performance Chart (2016 - 2020)
e-Therapeutics Plc, Ratio Charts
e-Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
e-Therapeutics Plc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[e-Therapeutics Plc (ETX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nestle Health Science SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Nestle Health Science SA (Nestle Health), a subsidiary of Nestle SA, is a health science company that manufactures nutritional and medicinal products derived from botanical plants. The company provides nutritional therapies for chronic conditions related to gastrointestinal diseases, aging p …
  • H. Lee Moffitt Cancer Center & Research Institute Inc-製薬・医療分野:企業M&A・提携分析
    Summary H. Lee Moffitt Cancer Center & Research Institute Inc (Moffitt) is a healthcare service provider that concentrates on the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services suc …
  • Avidity Biosciences LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Avidity Biosciences LLC (Avidity Biosciences), formerly Avidity NanoMedicines LLC is a biotech company that develops antibody oligonucleotide conjugates (AOCs). The company’s proprietary platform technology has enhanced pharmacokinetic and biodistribution properties that improves the deliver …
  • PRA Health Sciences Inc (PRAH):企業の財務・戦略的SWOT分析
    Summary PRA Health Sciences Inc (PRA) is a contract research organization (CRO) which provides clinical development services. The company offers services which include phase I-IV study management, bioanalytical services, biometrics, clinical pharmacology, strategic solutions, post-marketing research …
  • Achaogen Inc (AKAO):企業の財務・戦略的SWOT分析
    Summary Achaogen Inc (Achaogen) is a biopharmaceutical company that discovers, develops and commercializes novel antibacterial treatments for the treatment of multi-drug resistant and gram-negative infections. The company’s lead product, plazomicin used for the treatment of serious bacterial infecti …
  • California Cryobank-製薬・医療分野:企業M&A・提携分析
    Summary California Cryobank (CCB) is a healthcare service provider that offers reproductive, stem cell and donor selection services. The center offers services such as donor semen, pricing, donor information subscriptions, graduate donors, donor information, consultation services, genetic services, …
  • Vericel Corp (VCEL):企業の財務・戦略的SWOT分析
    Vericel Corp (VCEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Electricite du Liban:企業の戦略的SWOT分析
    Electricite du Liban - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Cynvenio Biosystems Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cynvenio Biosystems Inc (Cynvenio) is a cancer diagnostic company that focuses on transforming cancer treatment and management through the molecular analysis of cancer biomarkers in blood. The company offers products such as lab automation systems, isolation products and proprietary informat …
  • H&R Block, Inc.:戦略・SWOT・企業財務分析
    H&R Block, Inc. - Strategy, SWOT and Corporate Finance Report Summary H&R Block, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Enerflex Ltd (EFX):企業の財務・戦略的SWOT分析
    Enerflex Ltd (EFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • MediWound Ltd (MDWD):企業の財務・戦略的SWOT分析
    MediWound Ltd (MDWD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bloomberg L.P.:企業のM&A・事業提携・投資動向
    Bloomberg L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bloomberg L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Atossa Genetics Inc:企業のM&A・事業提携・投資動向
    Atossa Genetics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Atossa Genetics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Tri-State Generation and Transmission Association Inc:企業の戦略的SWOT分析
    Tri-State Generation and Transmission Association Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key com …
  • Cub Energy Inc (KUB):企業の財務・戦略的SWOT分析
    Summary Cub Energy Inc (Cub Energy), formerly 3P International Energy Corp is an oil and gas company that explores and develops oil and gas assets in Ukraine. The company operates its oil and gas exploration assets in Transcarpathian Basin and Dnieper-Donets Basin. Cub Energy uses technologies such …
  • Exact Sciences Corp (EXAS):製品パイプライン分析
    Summary Exact Sciences Corp (Exact) is a molecular diagnostic company that focuses on the early detection and prevention of various cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the early detection of …
  • Lund University-製薬・医療分野:企業M&A・提携分析
    Summary Lund University (LNU) is an educational service provider that offers master and bachelor programmes. It offers education and research in the areas of engineering, economics and management, science, law, social sciences, medicine, humanities, theology, fine art, music and others. The universi …
  • A.H.A International Co., Ltd.:企業の戦略・SWOT・財務分析
    A.H.A International Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary A.H.A International Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Cardiff University-製薬・医療分野:企業M&A・提携分析
    Summary Cardiff University is an educational institute that provides educational and research services. The institute offers services such as undergraduate courses, post graduate courses, international courses, accommodations, and libraries, among others. It conducts research in the areas of enginee …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆